Combined Oral Contraceptives
Mostrando 13-24 de 28 artigos, teses e dissertações.
-
13. The influence of combined oral contraceptives on the periodontal condition / A influência de contraceptivos orais combinados na condição periodontal
Durante as diferentes fases da vida, ocorrem alterações nos níveis dos hormônios sexuais no organismo. Estes períodos estão diretamente associados com episódios de inflamação periodontal exacerbada. Por isso, a relação entre níveis alterados dos hormônios sexuais e variações no grau de inflamação gengival tem sido estudada. Como os contracep
Publicado em: 2009
-
14. Oral contraceptives and tryptophan metabolism: Effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone
The effect upon tryptophan metabolism of the use of combined oestrogen-progestagen oral contraceptives containing a low (0·05 mg) dose of oestrogen, or of the continuous administration of megestrol acetate, has been studied by determining the excretion of tryptophan metabolites in urine collected after a 2 g oral dose of the amino acid.
-
15. Ovarian neoplasms, functional ovarian cysts, and oral contraceptives.
The incidence of ovarian neoplasms and functional ovarian cysts diagnosed at laparotomy or laparoscopy among the 17,000 women taking part in the Oxford Family Planning Association contraceptive study was investigated. Epithelial cancer of the ovary was only 25% as common among those who had ever taken oral contraceptives as those who had never done so (95% c
-
16. Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives
Objective: To explore the usefulness of epidemiological data to guide clinical practice by seeking an answer to the question “What is the risk of cardiovascular disease among users of currently available, low dose, combined oral contraceptives who are aged less than 35 years, do not smoke, and do not have a medical condition known to increase the risk of v
British Medical Journal.
-
17. Effectiveness and acceptability of progestogens in combined oral contraceptives – a systematic review
BioMed Central.
-
18. The immediate effects of the pill safety scare on usage of combined oral contraceptives in north east England.
-
19. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of General Practice Research Database
BMJ.
-
20. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of General Practice Research Database
British Medical Journal.
-
21. Coagulation studies in haemophilic patients taking oral contraceptives
Coagulation studies were performed on haemophilic patients during a controlled trial of oral contraceptive therapy. Treatment with a combined oestrogen-progestogen preparation was associated with a significant rise in the factor VII-X complex. This change was not observed during treatment with progestogen alone. The highest levels of factor IX and fibrinogen
-
22. Transient ischaemic attacks and increased platelet aggregability associated with oral contraceptives. Treatment with dipyridamole and aspirin.
A 24-year old woman after using birth control pills for two months began to suffer from frequent migraine-like attacks, which turned eventually into typical transient ischaemic attacks (TIAs). A significant increase in spontaneous platelet aggregation was found, and combined treatment with dipridamole and aspirin was started. After two months of treatment sp
-
23. Effect of local infection and oral contraception on immunoglobulin levels in cervical mucus.
The concentrations of immunoglobulin A (IgA) and immunoglobulin G (IgG) were estimated in cervical mucus from 115 patients attending a clinic for sexually transmitted diseases. The patients were divided into two groups; those using combined estrogen/progestogen oral contraceptives, and those with presumed normal ovulatory cycles. Gonorrhea, trichomoniasis, c
-
24. Risk factors for myocardial infarction in young women.
Seventy-seven women discharged from hospital with a diagnosis of myocardial infarction and 207 control patients were investigated. All were under 45 years of age at the time of admission. Heavy cigarette smoking, reported treatment for pre-eclamptic toxaemia, and type II hyperlipoproteinaemia were found to be independent risk factors for myocardial infarctio